---
figid: PMC2978223__1471-2148-10-305-1
figtitle: 'Daphnia pulex insulin and TOR signalling pathways, adapted from Drosophila
  melanogaster '
organisms:
- Drosophila melanogaster
- Daphnia pulex
- Homo sapiens
pmcid: PMC2978223
filename: 1471-2148-10-305-1.jpg
figlink: /pmc/articles/PMC2978223/figure/F1/
number: F1
caption: Daphnia pulex insulin and TOR signalling pathways, adapted from Drosophila
  melanogaster []. The D. pulex insulin/insulin-like growth factors signalling (IIS)
  comprises a group of insulin-like peptides (ILPs), four insulin receptors (InR1,
  InR2, InR3 and InR4) genes, an insulin receptor substrate (IRS), the type phosphatidylinositol-3-kinase
  (PI3K p85/p60 and PI3K p110), the lipid phosphatase PTEN, the protein kinase PKB/AKT,
  the phosphoinositide-dependent protein kinase 1 (PDK-1) and the transcriptional
  factor FOXO. The TOR- pathway includes a TSC complex (TSC1 and TSC2), a small GTPase
  RHEB, the target of rapamycin (TOR), two S6 kinase (S6K1 and S6K2), the 4E-binding
  protein (4EBP) and the Pol I transcription factor TIF-1A. The AMPK-pathway involves
  the activation of AMP-dependent kinase (AMPK) by the LKB1 protein kinase.
papertitle: Unusual duplication of the insulin-like receptor in the crustacean Daphnia
  pulex.
reftext: Philippe Boucher, et al. BMC Evol Biol. 2010;10:305-305.
year: '2010'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9512072
figid_alias: PMC2978223__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC2978223__F1
ndex: 5db1774e-def0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2978223__1471-2148-10-305-1.html
  '@type': Dataset
  description: Daphnia pulex insulin and TOR signalling pathways, adapted from Drosophila
    melanogaster []. The D. pulex insulin/insulin-like growth factors signalling (IIS)
    comprises a group of insulin-like peptides (ILPs), four insulin receptors (InR1,
    InR2, InR3 and InR4) genes, an insulin receptor substrate (IRS), the type phosphatidylinositol-3-kinase
    (PI3K p85/p60 and PI3K p110), the lipid phosphatase PTEN, the protein kinase PKB/AKT,
    the phosphoinositide-dependent protein kinase 1 (PDK-1) and the transcriptional
    factor FOXO. The TOR- pathway includes a TSC complex (TSC1 and TSC2), a small
    GTPase RHEB, the target of rapamycin (TOR), two S6 kinase (S6K1 and S6K2), the
    4E-binding protein (4EBP) and the Pol I transcription factor TIF-1A. The AMPK-pathway
    involves the activation of AMP-dependent kinase (AMPK) by the LKB1 protein kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ilp6
  - Ilp7
  - Ilp1
  - Ilp2
  - Ilp3
  - Ilp4
  - Ilp8
  - Ilp5
  - IRSp53
  - IleRS
  - chico
  - Tsc1
  - gig
  - ATPsynbeta
  - Atpalpha
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Lkb1
  - SNF4Agamma
  - AMPKalpha
  - Pten
  - foxo
  - tor
  - Tor
  - Egfr
  - S6k
  - Thor
  - Tif-IA
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - TSC1
  - CCL26
  - TSC2
  - ATP8A2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - STK11
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PTEN
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - RORC
  - RPS6KB1
  - RRN3
  - Glucose
  - Cancer
---
